It has been used experimentally to protect veterinary and laboratory personnel at high risk of exposure to RVF.

The WHO public health approach to scale-up emphasizes simplified and standardized drug regimens, decentralized services and judicious use of personnel and laboratory infrastructure; and

Vaccination is only recommended as a prophylactic measure for high-risk groups (e.g. laboratory personnel who are constantly exposed to the risk of contamination).